Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine - Wikidata - awgldk - TriplyDB

Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine

Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine

http://www.wikidata.org/entity/Q27024626

about

Studying Cellular Signal Transduction with OMIC Technologies Cancer prevention: state of the art and future prospects New obesity classification criteria as a tool for bariatric surgery indication The proteomic landscape of triple-negative breast cancer.Precision targeted therapy of ovarian cancer Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials Integrating dynamic mixed-effect modelling and penalized regression to explore genetic association with pharmacokinetics Wireless Wearable Multisensory Suite and Real-Time Prediction of Obstructive Sleep Apnea Episodes.An Altered Treatment Plan Based on Direct to Consumer (DTC) Genetic Testing: Personalized Medicine from the Patient/Pin-cushion Perspective.Integration and Visualization of Translational Medicine Data for Better Understanding of Human Diseases.Integrative analysis of human omics data using biomolecular networks.Systems Chronotherapeutics Individually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factors Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells.Label-free microcavity biosensors: steps towards personalized medicine.Analytical challenges translating mass spectrometry-based phosphoproteomics from discovery to clinical applications.Unbiased approaches to biomarker discovery in neurodegenerative diseases Managing large-scale genomic datasets and translation into clinical practice.Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area.Multi-study integration of brain cancer transcriptomes reveals organ-level molecular signatures Recent developments in proteomic methods and disease biomarkers.Oncoproteomics: Trials and tribulations.End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.The ABRF Metabolomics Research Group 2013 Study: Investigation of Spiked Compound Differences in a Human Plasma Matrix.Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability Is phosphoproteomics ready for clinical research?A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction.Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers.Personalized oncology in interventional radiology.Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.Understanding complexity in neurodegenerative diseases: in silico reconstruction of emergence.Network approaches to drug discovery.Genomic biomarkers for patient selection and stratification: the cancer paradigm.Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.Deciphering the single-cell omic: innovative application for translational medicine.Genome-scale modeling of human metabolism - a systems biology approach.Update on biomarkers of hepatocellular carcinoma.Mathematical modeling for novel cancer drug discovery and development.Construction and Validation of a Multi-Institutional Tissue Microarray of Invasive Ductal Carcinoma From Racially and Ethnically Diverse Populations.

P2860

Q24289429-8322F941-E980-4279-88CC-7FFA7E5F64DE Q26770668-523CFE0F-6FC6-47A3-95B1-DB94F373056A Q26774656-0F7366BF-4CD0-4570-8CD1-A41F2DAA9C39 Q27320721-7EA4B932-13C6-4FBF-BF2C-242BA1035BF1 Q28078658-EA2523EE-D900-45A4-917E-95C64D0ADF81 Q28385880-4508E2E4-6CCC-4457-8675-3EF280BA0521 Q28540955-CE923B77-A3E0-4CFB-B5D6-726C085D8DE0 Q28650281-C4B7DE8A-3021-4F54-A881-DE2A5DC03ADF Q30383881-2C65D818-BFF5-4E44-AD9E-5301B587728C Q30409124-752EF757-2EB2-43ED-8FFD-C3B2C175D807 Q31116335-7D941260-9875-4E62-956B-9A87D216805A Q31120979-B4EB6B8B-3709-4A88-8D07-22917F63BB42 Q33573675-26A61FE7-CCCF-4EC9-8BA6-B22139F26031 Q34413219-4B2A877B-23DE-4744-BE8A-A0BF93001259 Q34441724-0496E858-71FD-462A-B5A5-35B94069911D Q34601506-39B7CB45-29F8-426B-8200-3FBC6E9D1CF5 Q34604043-CB601D3E-5942-4872-82C7-A71B446F68BE Q34625918-42F63BFB-EA5C-4C18-B18F-85320F78737A Q34868762-7766C256-DEC0-4FFE-8F66-70706BB6B6F8 Q34879739-12E5F906-0993-4D7A-BC6E-C59E301796B9 Q34916522-20E1616A-3999-4384-A789-D1309654A2F3 Q35197167-4EE6732C-8039-4D78-B693-7402D0433322 Q35827653-B918476F-2FB5-473A-ACB0-E4E4A6762CE5 Q35917987-03D8AE87-A061-404C-B028-492AC40B9706 Q35966041-B476E9C6-2132-491C-A965-047C509F209E Q36689829-5067DCD9-2256-4846-A204-2B24F989890F Q36799469-6B918912-E30D-4D26-814B-8F8F3F1A5EDC Q36951545-BBA72C63-4C92-47A8-A0FA-A197C2ECA8B1 Q37081947-E95605A6-FD16-4F54-8DBF-594B3D632DE3 Q37092371-E461C792-AF77-4227-BA19-FA2015203CA0 Q37552845-42A79754-58CD-4930-B889-5A9906033161 Q38039079-9B738DF4-4300-4058-830C-A8678CD4ED41 Q38058888-15203DAD-6BB8-4FE9-90BA-DA6D7637D12B Q38060203-024BA652-D9E9-4F43-A94A-01878E09C1E0 Q38068925-AD5D616F-CEC4-41D9-B9D3-D3049E38E721 Q38068927-ABDDA9DC-66A6-4C30-BD5D-107F3A5E7519 Q38101307-2E91F615-7D6D-4374-804B-7BA11507E0D5 Q38166133-CC7F1622-36B3-4557-A95B-6CCAFEE0AEE8 Q38233988-403C91D3-A2F8-4625-BCBB-B57C8A215BDF Q38375829-3E8F8A07-B285-47C5-865C-8D87AFF2A44B

P2860

Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine

http://www.wikidata.org/entity/Q27024626

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Systems cancer medicine: towar ...... nd participatory (P4) medicine

@ast

Systems cancer medicine: towar ...... nd participatory (P4) medicine

@en

Systems cancer medicine: towar ...... nd participatory (P4) medicine

@nl

type

label

Systems cancer medicine: towar ...... nd participatory (P4) medicine

@ast

Systems cancer medicine: towar ...... nd participatory (P4) medicine

@en

Systems cancer medicine: towar ...... nd participatory (P4) medicine

@nl

prefLabel

Systems cancer medicine: towar ...... nd participatory (P4) medicine

@ast

Systems cancer medicine: towar ...... nd participatory (P4) medicine

@en

Systems cancer medicine: towar ...... nd participatory (P4) medicine

@nl

P1433

Q27024626-F33EA59E-3E56-440E-8D39-65D653C1E5D8

P1476

Q27024626-00CC0205-6BFB-4376-AEF1-200BF6C6614F

P2093

Q27024626-0FE5A644-091A-4B15-964F-02775BD3D47A

Q27024626-6162FB4A-C8F0-4D99-AC62-0BF819BBAD07

P2860

Q27024626-06BAD34D-8917-4ACB-8B76-F3D7BF3F7214

Q27024626-0C0A3AFD-C48F-410D-B16E-90CA33B44C54

Q27024626-16A15017-8AF7-4B67-8912-040F28B1371A

Q27024626-18AFD7C8-5E11-4D54-83E6-5F20AB84FAAA

Q27024626-2CE6E262-5493-4674-8046-B067BC568EB7

Q27024626-3124C69B-B42A-409D-BE2F-9DB945E579F4

Q27024626-3A7CFCC6-4AF4-4817-A717-22AF7621ABB2

Q27024626-3EBC78CF-9D93-4E01-8952-7A6FC600B78B

Q27024626-40D640D6-D03A-4521-A636-3B67FB083372

Q27024626-43A4E40F-3E22-4BA9-9A3A-687336A8669A

P304

Q27024626-2041B207-EF08-46B0-BA59-DAB4401E4609

P31

Q27024626-08C63284-7473-4445-89D9-53C018E57F36

P3181

Q27024626-8DD024F0-9318-44DC-BE5A-946DDE5E639E

P356

Q27024626-3C89E79D-435F-4BE6-BA73-AB96647F7355

P407

Q27024626-320A60D5-67ED-417F-BBAF-6B0DBFAC8C2E

P433

Q27024626-D0FE75BB-9CB7-4BC1-BADB-BAD0865C8772

P478

Q27024626-32D9EC3E-6D8B-411E-89F6-0D744A607F8C

P50

Q27024626-AAAA41EA-1932-4032-9B1C-E09B57A1CBFB

P577

Q27024626-7C859B4E-1B49-446B-9F21-A59881B57A2F

P5875

Q27024626-80D33E89-8618-4293-BB79-A3E888CF97C6

P698

Q27024626-3DB744C4-DAD8-45FC-91CA-949A7276911D

P932

Q27024626-11C6C0FA-1770-4356-BC69-478E14511A04

P3181

P356

J.1365-2796.2011.02498.X

P1433

Journal of Internal Medicine

P1476

Systems cancer medicine: towar ...... nd participatory (P4) medicine

@en

P2093

L Hood

http://www.w3.org/2001/XMLSchema#string

Q Tian

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of genetic inheritance in a family quartet by whole-genome sequencing

Hallmarks of Cancer: The Next Generation

BRAF mutations in hairy-cell leukemia

The genomic complexity of primary human prostate cancer

A comprehensive catalogue of somatic mutations from a human cancer genome

Initial genome sequencing and analysis of multiple myeloma

Recurring mutations found by sequencing an acute myeloid leukemia genome

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

An integrated genomic analysis of human glioblastoma multiforme

Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing

P304

111-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1345673

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1365-2796.2011.02498.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

271

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51853529

http://www.w3.org/2001/XMLSchema#string

P698

22142401

http://www.w3.org/2001/XMLSchema#string

P932

3978383

http://www.w3.org/2001/XMLSchema#string